# HALOBETASOL PROPIONATE
> **ANDA215266** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2023-08-11
## Drug
- **FDA Application Number:** ANDA215266
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HALOBETASOL PROPIONATE
- **Generic name:** HALOBETASOL PROPIONATE
- **Active ingredients:** HALOBETASOL PROPIONATE
- **Dosage form:** AEROSOL, FOAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** PADAGIS ISRAEL
- **Manufacturer:** Mayne Pharma
- **First approval:** 2023-08-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215266)
---
*MORVS · CC0 1.0*